Effects of palbociclib in oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
Objective: Lack of effective therapies remains a problem in the treatment of oral squamous cell carcinoma (OSCC), especially in patients with advanced tumors. OSCC development is driven by multiple aberrancies within the cell cycle pathway, including amplification of cyclin D1 and loss of p16. Hence...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Chinese Anti-cancer Association
2019
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/23892/1/cbm-16-2-264.pdf |